These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 25545771)
1. Abnormal nuclear expression of Pygopus-2 in human primary hepatocellular carcinoma correlates with a poor prognosis. Zhang S; Li J; He F; Wang XM Histopathology; 2015 Aug; 67(2):176-84. PubMed ID: 25545771 [TBL] [Abstract][Full Text] [Related]
2. Loss of SFRP1 Expression Is Associated with Poor Prognosis in Hepatocellular Carcinoma. Davaadorj M; Imura S; Saito YU; Morine Y; Ikemoto T; Yamada S; Takasu C; Hiroki T; Yoshikawa M; Shimada M Anticancer Res; 2016 Feb; 36(2):659-64. PubMed ID: 26851021 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma. Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of long non-coding RNA PCAT-1 expression in human hepatocellular carcinoma. Yan TH; Yang H; Jiang JH; Lu SW; Peng CX; Que HX; Lu WL; Mao JF Int J Clin Exp Pathol; 2015; 8(4):4126-31. PubMed ID: 26097602 [TBL] [Abstract][Full Text] [Related]
5. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703 [TBL] [Abstract][Full Text] [Related]
6. Expression pattern and clinicopathologic significance of NKD1 in human primary hepatocellular carcinoma. Zhang S; Li J; Yin ZY; Liu PG; Zhao WX; Xie CR; Zhao BX; Wang XM APMIS; 2015 Apr; 123(4):315-20. PubMed ID: 25706354 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients. Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282 [TBL] [Abstract][Full Text] [Related]
8. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma. Cai L; Cai X Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinoma. Ng KT; Qi X; Kong KL; Cheung BY; Lo CM; Poon RT; Fan ST; Man K Eur J Cancer; 2011 Oct; 47(15):2299-305. PubMed ID: 21683576 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of activated Cdc42-associated kinase1 (Ack1) predicts tumor recurrence and poor survival in human hepatocellular carcinoma. Wang B; Xu T; Liu J; Zang S; Gao L; Huang A Pathol Res Pract; 2014 Dec; 210(12):787-92. PubMed ID: 25445114 [TBL] [Abstract][Full Text] [Related]
11. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma. Kuo CC; Shih YL; Su HY; Yan MD; Hsieh CB; Liu CY; Huang WT; Yu MH; Lin YW World J Gastroenterol; 2015 Apr; 21(13):3960-9. PubMed ID: 25852282 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of FOXP1 as an oncogene in hepatocellular carcinoma. Zhang Y; Zhang S; Wang X; Liu J; Yang L; He S; Chen L; Huang J J Clin Pathol; 2012 Jun; 65(6):528-33. PubMed ID: 22422806 [TBL] [Abstract][Full Text] [Related]
13. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma. Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000 [TBL] [Abstract][Full Text] [Related]
14. Expression of NEDD9 in hepatocellular carcinoma and its clinical significance. Lu P; Wang ZP; Dang Z; Zheng ZG; Li X; Zhou L; Ding R; Yue SQ; Dou KF Oncol Rep; 2015 May; 33(5):2375-83. PubMed ID: 25812772 [TBL] [Abstract][Full Text] [Related]
15. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285 [TBL] [Abstract][Full Text] [Related]
16. Relationship between the expression of MDR1 in hepatocellular cancer and its biological behaviors. Gao B; Yang FM; Yu ZT; Li R; Xie F; Chen J; Luo HJ; Zhang JC Int J Clin Exp Pathol; 2015; 8(6):6995-7001. PubMed ID: 26261589 [TBL] [Abstract][Full Text] [Related]
17. Decreased expression of liver-type fatty acid-binding protein is associated with poor prognosis in hepatocellular carcinoma. Wang B; Tao X; Huang CZ; Liu JF; Ye YB; Huang AM Hepatogastroenterology; 2014; 61(133):1321-6. PubMed ID: 25436304 [TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor binding protein-1 inhibits cancer cell invasion and is associated with poor prognosis in hepatocellular carcinoma. Dai B; Ruan B; Wu J; Wang J; Shang R; Sun W; Li X; Dou K; Wang D; Li Y Int J Clin Exp Pathol; 2014; 7(9):5645-54. PubMed ID: 25337205 [TBL] [Abstract][Full Text] [Related]
19. Metastasis-related miR-185 is a potential prognostic biomarker for hepatocellular carcinoma in early stage. Zhi Q; Zhu J; Guo X; He S; Xue X; Zhou J; Hu B; Li H; Chen S; Zhao H; Kuang Y Biomed Pharmacother; 2013 Jun; 67(5):393-8. PubMed ID: 23648054 [TBL] [Abstract][Full Text] [Related]
20. Upregulation of Leucine Zipper Protein mRNA in Hepatocellular Carcinoma Associated With Poor Prognosis. Li G; Yuan L; Liu D; Liu J Technol Cancer Res Treat; 2016 Jun; 15(3):517-22. PubMed ID: 26031464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]